SHANNON WOODS: Open Payments
NPI 1487072864 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 44 payments from 10 companies in 2025. Trend: 2023 $3,601 · 2024 $5,455 · 2025 $1,421
Food & beverage: $771Consulting: $549Education: $101
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $630 |
| AstraZeneca Pharmaceuticals LP | 3 | $264 |
| Amgen Inc. | 19 | $223 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| Electromed, Inc. | 6 | $70 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| Viatris Specialty LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Ionis Pharmaceuticals, Inc. | 1 | $14 |
Products named: DUPIXENT, TEZSPIRE, SMARTVEST, NUCALA, NEFFY, YUPELRI, TAKHZYRO, DAWNZERA.
Industry payments across MS — which companies pay providers there.
